Merck KGaA (XTER:MRK)
€ 152.25 1.4 (0.93%) Market Cap: 66.19 Bil Enterprise Value: 74.13 Bil PE Ratio: 24.98 PB Ratio: 2.30 GF Score: 90/100

Merck KGaA CMD - Healthcare:R&D Update Call Transcript

Sep 25, 2020 / 12:30PM GMT
Release Date Price: €124 (+0.24%)
Operator

Ladies and gentlemen, welcome to Merck's R&D Update Call 2020. (Operator Instructions)

May I now hand you over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest
MERCK Kommanditgesellschaft auf Aktien - Head of IR

Thank you, Abby. Dear, ladies and gentlemen, a very, very warm welcome to this R&D Update Call. My name is Constantin Fest. I'm Head of Investor Relations here at Merck. And it's great to have all of you here joining this call, which is also the third deep dive session of last week's Capital Markets Day. And this is why I'd like to directly hand over to Amelie Schrader, Director, Investor Relations and Principal Healthcare Lead, to kick off this deep dive.

Amelie Schrader

Thank you, Constantin. Dear, ladies and gentlemen, a very warm welcome also from my side. I kindly ask you to please turn to Page 3 of the slide deck for a brief introduction of the 4 representatives of our R&D and commercial leadership joining us

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot